ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 4,5,6,7-tetrabromobenzimidazole. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

16 träffar

Bibliografisk träff 2024-10-10

Synthesis and evaluation of anticancer activity of new 4,5,6,7-tetrabromo-1H-benzimidazole derivatives.

Łukowska-Chojnacka E, Fedorov E, Kowalkowska A, Wielechowska M, Sobiepanek A, Koronkiewicz M, Wińska P.

Bioorg Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bioorg.2024.107880

Bibliografisk träff 2020-11-24

Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase.

Chojnacki K, Lindenblatt D, Wińska P, Wielechowska M, Toelzer C, Niefind K, Bretner M.

Bioorg Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bioorg.2020.104502

Bibliografisk träff 2017-03-22

SlgA, encoded by the homolog of the human schizophrenia-associated gene <i>PRODH</i>, acts in clock neurons to regulate <i>Drosophila</i> aggression.

Zwarts L, Vulsteke V, Buhl E, Hodge JJL, Callaerts P.

Dis Model Mech · research support, non-u.s. gov't; research-article; journal article · DOI 10.1242/dmm.027151

Bibliografisk träff 2015-12-24

Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.

Łukowska-Chojnacka E, Wińska P, Wielechowska M, Poprzeczko M, Bretner M.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2015.12.041

Bibliografisk träff 2015-11-12

Acetoxymethyl Ester of Tetrabromobenzimidazole-Peptoid Conjugate for Inhibition of Protein Kinase CK2 in Living Cells.

Viht K, Saaver S, Vahter J, Enkvist E, Lavogina D, Sinijärv H, Raidaru G, Guerra B, Issinger OG, Uri A.

Bioconjug Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.bioconjchem.5b00383

Bibliografisk träff 2014-11-18

Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.

Leung KK, Shilton BH.

Biochemistry · research support, non-u.s. gov't; journal article · DOI 10.1021/bi500959t

Bibliografisk träff 2014-03-05

Quantum-chemical insight into structure-reactivity relationship in 4,5,6,7-tetrahalogeno-1H-benzimidazoles: a combined X-ray, DSC, DFT/QTAIM, Hirshfeld surface-based, and molecular docking approach.

Latosińska JN, Latosińska M, Maurin JK, Orzeszko A, Kazimierczuk Z.

J Phys Chem A · research support, non-u.s. gov't; journal article · DOI 10.1021/jp411547z

Bibliografisk träff 2013-01-27

Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.

Cozza G, Sarno S, Ruzzene M, Girardi C, Orzeszko A, Kazimierczuk Z, Zagotto G, Bonaiuto E, Di Paolo ML, Pinna LA.

Biochim Biophys Acta · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbapap.2013.01.018

Bibliografisk träff 2010-01-15

Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes.

Mikula M, Hanusek K, Paziewska A, Dzwonek A, Rubel T, Bomsztyk K, Ostrowski J.

BMC Mol Biol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1471-2199-11-4

Bibliografisk träff 2008-11-01

The selectivity of inhibitors of protein kinase CK2: an update.

Pagano MA, Bain J, Kazimierczuk Z, Sarno S, Ruzzene M, Di Maira G, Elliott M, Orzeszko A, Cozza G, Meggio F, Pinna LA.

Biochem J · research support, non-u.s. gov't; journal article · DOI 10.1042/bj20080309

Bibliografisk träff 2008-06-12

New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole.

Bretner M, Najda-Bernatowicz A, Łebska M, Muszyńska G, Kilanowicz A, Sapota A.

Mol Cell Biochem · research support, non-u.s. gov't; journal article · DOI 10.1007/s11010-008-9827-0

Bibliografisk träff 2008-02-07

An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.

Duncan JS, Gyenis L, Lenehan J, Bretner M, Graves LM, Haystead TA, Litchfield DW.

Mol Cell Proteomics · research support, non-u.s. gov't; journal article · DOI 10.1074/mcp.m700559-mcp200

Bibliografisk träff 2005-09-15

Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2.

Zien P, Duncan JS, Skierski J, Bretner M, Litchfield DW, Shugar D.

Biochim Biophys Acta · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.bbapap.2005.07.039

Bibliografisk träff 2004-12-01

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.

Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, Bain J, Elliott M, Meggio F, Kazimierczuk Z, Pinna LA.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm049854a

Bibliografisk träff 2003-12-01

TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications.

Zień P, Abramczyk O, Domańska K, Bretner M, Szyszka R.

Biochem Biophys Res Commun · comparative study; journal article · DOI 10.1016/j.bbrc.2003.10.165

Bibliografisk träff 2003-06-01

Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources.

Zień P, Bretner M, Zastapiło K, Szyszka R, Shugar D.

Biochem Biophys Res Commun · research support, non-u.s. gov't; journal article · DOI 10.1016/s0006-291x(03)00928-8